Shop Lands' End and Help Cure Cancer

Greetings! The holidays are upon us! The Leukemia & Lymphoma Society (LLS) has a great strategy for you to avoid the crowds and make your gifts to loved ones, friends and colleagues even more special. Thanks to our new partnership with renowned apparel…Read More

Support our year-end campaign and help create a world free of blood cancers!

Dear Friend, I hope you and your family had a wonderful Thanksgiving holiday.  In our home, it is a time of great company, abundant food and reflection, for we have much to give thanks for.   I want to thank you for the support you've provided The Leukemia…Read More

Happy Holidays from LLS!

"This is the season for kindling the fire of hospitality in the hall, the genial flame of charity in the heart." -- Washington Irving (1783 - 1859)   The Leukemia & Lymphoma Society (LLS) wishes you and your loved ones a happy and healthy holiday…Read More

Greetings from your friends at LLS

We're hoping this finds you well and ready for the holidays! As a Causes Administrator you're probably aware that the end of the year is a popular time for nonprofit fundraising campaigns - thanks to the tax incentives those gifts offer. Please consider…Read More

Thanks to our donors and supporters!

Dear Friend. On behalf of everyone touched by blood cancers, we thank you for your contributions and commitment to supporting The Leukemia & Lymphoma Society (LLS) last year.  When a person has been supporting cancer research, as you have been, we feel…Read More

This Halloween - take a bite out of cancer!

  (   ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- h…Read More

The Importance of Accelerating New Therapies

Dear Friend of LLS: Because blood cancers are considered 'orphan diseases' with small markets and lower profit potential, there is little financial incentive for pharmaceutical companies to invest in new treatments, particularly at the preclinical or early…Read More
See more


to comment